REFERENCES

  1. Watchko, J.F. and C. Tiribelli, Bilirubin-Induced Neurologic Damage — Mechanisms and Management Approaches. New England Journal of Medicine, 2013. 369(21): p. 2021-2030.

  2. Douglas M Campbell, M., Karoon C Danayan, M., Valleverdina McGovern, R., Sohail Cheema, M., Brenda Stade, R., and Michael Sgro, M., Transcutaneous Bilirubin Measurement at the Time of Hospital Discharge in a Multiethnic Newborn Population. Paediatric Child Health, 2011. 16(3): p. 141-145.

  3. Subcommittee on Hyperbilirubinemia, Management of Hyperbilirubinemia in the Newborn Infant 35 or More Weeks of Gestation. Pediatrics, 2004. 114(1): p. 297-316.

  4. Lamola, A.A., Eisinger, J., Blumberg, W.E., Patel, S.C., and Flores, J., Fluorometric Study of Partition of Bilirubin Among Blood Components: Basis for Rapid Microassays of Bilirubin and Bilirubin Binding Capacity in Whole Blood. Analytical Biochemistry, 1979. 100: p. 25-42.

  5. Wells, R., Hammond, K., Lamola, A.A., and Blumberg, W.E. (1982). Relationships of Bilirubin Binding Parameters. Clinical chemistry 28, 432-439.

  6. Lamola, A.A., Bhutani, V.K., Du, L., Castillo Cuadrado, M., Chen, L., Shen, Z., Wong, R.J., and Stevenson, D.K. Neonatal bilirubin binding capacity discerns risk of neurological dysfunction. Pediatr Res 2015. 77, 334-339.